HRT Financial’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-127,998
| Closed | -$453K | – | 2232 |
|
2025
Q1 | $453K | Buy |
+127,998
| New | +$453K | ﹤0.01% | 1334 |
|
2024
Q4 | – | Sell |
-81,291
| Closed | -$263K | – | 2168 |
|
2024
Q3 | $263K | Buy |
81,291
+51,748
| +175% | +$167K | ﹤0.01% | 1707 |
|
2024
Q2 | $56K | Buy |
+29,543
| New | +$56K | ﹤0.01% | 1647 |
|
2024
Q1 | – | Sell |
-42,192
| Closed | -$621K | – | 2134 |
|
2023
Q4 | $621K | Buy |
42,192
+16,098
| +62% | +$237K | ﹤0.01% | 1152 |
|
2023
Q3 | $477K | Sell |
26,094
-23,112
| -47% | -$422K | ﹤0.01% | 1275 |
|
2023
Q2 | $1.06M | Sell |
49,206
-44,584
| -48% | -$961K | 0.01% | 853 |
|
2023
Q1 | $2.75M | Buy |
+93,790
| New | +$2.75M | 0.03% | 435 |
|